NAMI
PRCT icon

Nomura Asset Management International’s Procept Biorobotics PRCT Stock Holding History

Nomura Asset Management International’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
+82,153
New +$2.06M ﹤0.01% 1094
2026
Q1 		– Sell
-194,041
Closed -$6.11M – 1297
2025
Q4 		$6.11M Buy
+194,041
New +$6.43M 0.01% 775

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nomura Asset Management International's PRCT Position: Q2 2026 in Review

Nomura Asset Management International opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 82,153 shares worth $1.85M. The stake represents ﹤0.01% of the portfolio and ranks #1094 among its holdings. This is a return to the name: Nomura Asset Management International previously reported a position in PRCT as recently as Q4 2025.

Nomura Asset Management International first reported a position in PRCT in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.11M in Q4 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Nomura Asset Management International held 82,153 shares of Procept Biorobotics worth $1.85M as of Q2 2026.
  • Procept Biorobotics was a new Nomura Asset Management International position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1094 holding.
  • Nomura Asset Management International first reported a position in Procept Biorobotics in Q4 2025 and has held it in 2 quarters since.
  • Nomura Asset Management International's Procept Biorobotics position peaked at $6.11M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.